Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Aethlon Medical, Inc.
Healthcare
P/NCAV
0.57x
Ticker
AEMD
Exchange
NASDAQ
Country
United States
Close
1.51 $
Mkt Cap
3.1M $
EV
-4.9M $
NCAV Burn Rate
63.2%
Current Ratio
3.93
Debt/Equity
0.0
EV/REV
-8.48x
EV/EBIT
0.4x
EV/FCF
0.5x
Dilution
62.5% p.A
Total Net Income
-80.9M $
Cheapness
95.0%
Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average